Evidence map›Paper›PMID 35371524›Full record

ArticleNeuro-oncology practice2022

Optimal timing of radiotherapy following brain metastases surgery.

Nasser K Yaghi, Stephanie Radu, Joseph G Nugent, David J Mazur-Hart, Brandi W Pang, Stephen G Bowden, Blair Murphy, Seunggu J Han

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nasser K YaghiNeurological Surgery, Oregon Health & Sciences University, Portland, Oregon, USA.
Stephanie RaduNeurological Surgery, Oregon Health & Sciences University, Portland, Oregon, USA.
Joseph G NugentNeurological Surgery, Oregon Health & Sciences University, Portland, Oregon, USA.
David J Mazur-HartNeurological Surgery, Oregon Health & Sciences University, Portland, Oregon, USA.
Brandi W PangNeurological Surgery, Oregon Health & Sciences University, Portland, Oregon, USA.
Stephen G BowdenNeurological Surgery, Oregon Health & Sciences University, Portland, Oregon, USA.
Blair MurphyRadiation Medicine, Oregon Health & Sciences University, Portland, Oregon, USA.
Seunggu J HanNeurosurgery, Stanford University, Stanford, California, USA.ORCID https://orcid.org/0000-0002-6944-3745

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is growing evidence supporting the need for a short time delay before starting radiotherapy (RT) treatment postsurgery for most optimal responses. The timing of RT initiation and effects on outcomes have been evaluated in a variety of malignancies, but the relationship remains to be well established for brain metastasis. Methods: Retrospective study of 176 patients (aged 18-89 years) with brain metastases at a single institution (March 2009 to August 2018) who received RT following surgical resection. Time interval (≤22 and >22 days) from surgical resection to initiation of RT and any potential impact on patient outcomes were assessed. Results: Patients who underwent RT >22 days after surgical resection had a decreased risk for all-cause mortality of 47.2% (95% CI: 8.60, 69.5%). Additionally, waiting >40 days for RT after surgical resection more than doubled the risk of tumor progression; adjusted hazard ratio 2.02 (95% CI: 1.12, 3.64). Conclusions: Findings indicate that a short interval delay (>22 days) following surgical resection is required before RT initiation for optimal treatment effects in brain metastasis. Our timing of RT postsurgical resection data adds definition to current heterogeneity in RT timing, which is especially important for standardized clinical trial design and patient outcomes.

Indexed as

adjuvant therapybrain metastasispostoperativeradiationtreatment timing

Identifiers

PMID35371524
PMCPMC8965066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.